Which opioid analgesic is commonly used to pharmacologically treat neonatal abstinence syndrome?

Which opioid analgesic is commonly used to pharmacologically treat neonatal abstinence syndrome?

• A. Morphine
• B. Fentanyl
• C. Hydrocodone
• D. Codeine

Answer: (A)

Neonatal abstinence syndrome involves withdrawal symptoms in a newborn exposed to opioids in utero. To manage this, clinicians use opioid substitution therapy, giving a controlled opioid to the infant and then gradually tapering it as symptoms improve. Morphine is the most commonly used agent for this purpose because its dosing can be precisely titrated to the infant’s withdrawal severity, it has extensive neonatal experience and clear tapering protocols, and it reliably reduces irritability, tremors, feeding difficulties, and other NAS symptoms. Other opioids like fentanyl, hydrocodone, or codeine aren’t standard first-line treatments for NAS due to less established neonatal protocols or safety/metabolism considerations in newborns.

Neonatal abstinence syndrome involves withdrawal symptoms in a newborn exposed to opioids in utero. To manage this, clinicians use opioid substitution therapy, giving a controlled opioid to the infant and then gradually tapering it as symptoms improve. Morphine is the most commonly used agent for this purpose because its dosing can be precisely titrated to the infant’s withdrawal severity, it has extensive neonatal experience and clear tapering protocols, and it reliably reduces irritability, tremors, feeding difficulties, and other NAS symptoms. Other opioids like fentanyl, hydrocodone, or codeine aren’t standard first-line treatments for NAS due to less established neonatal protocols or safety/metabolism considerations in newborns.